PROSHARES ULTRAPRO S&P500 PROSHARES ETF News

View: Source For the first time in many years, the precious metal universe has outpaced the S&P 500 and Dow. This has been the case since The post Silver will show the way appeared first on MineralPrices.com .

November has historically been one of the best months of the year for the S&P 500 since 1950. However, this year’s November proved a bit different. The month started off well and the robust performance continued until the last few days, when concerns over the new COVID-19 variant pushed many investors away. Still, there were […]

Apollo Global Management Inc. said Thursday it has agreed to acquire the U.S. wealth distribution and asset management businesses of Griffin Capital, adding more than $5 billion in assets under management. Terms of the deal were not disclosed, although the private-equity giant said it expects to close in the first half of 2022 and to be breakeven to per-share earnings in 2022 and become a "meaningful" driver of earnings growth in the coming years. Griffin was formed in 1995 and has built a track record as a provider of alternative investments to advisors in the U.S. "Griffin''s approximately 60 client-facing distribution professionals work across the wealth management landscape and are particularly well-established in the independent channel, a complement to Apollo''s focus to-date on private banks, wirehouses, RIAs and family offices," the company said in a statement. "Apollo intends to integrate the team into its Global Wealth business, rapidly scaling the strategic initiative. The acquisition also adds valuable technology, infrastructure and hundreds of distribution agreements to the Global Wealth platform." Apollo shares were not yet active premarket, but have gained 44% in the year to date, while the S&P 500 has gained 20%.

Dow industrial average and S&P index are still lower The NASDAQ index is currently up 37 points or 0.24% 15820.70. The S&P index and Dow industrial average remains negative: By Greg Michalowski

Shares of First Wave BioPharma Inc. rocketed 46.6% on very heavy volume in premarket trading Tuesday, after the biopharmaceutical company said an independent data monitoring committee (DMC) recommended continued enrollment in a Phase 2 trial of its treatment (FW-COV) for COVID-19-related gastrointestinal (GI) infections. Trading volume spiked to 12.0 million shares ahead of the open, enough to make the stock the most actively traded in the premarket, and compared with the full-day average of about 1.4 million shares. FW-COV is an oral tablet developed to remove SARS-CoV-2 from the GI tract. The DMC recommendation was based on its review of safety data, as no safety issues were uncovered. "Because niclosamide targets the entire virus, and not just the spike protein, we believe that FW-COV may prove effective against multiple strains of COVID-19 and may provide an effective therapeutic to help millions of COVID-19 patients overcome the debilitating and often overlooked effect the virus can have on the GI system," said Chief Executive James Sapirstein.

Forex news from the European trading session - 30 November 2021 Headlines: Markets: - EUR leads, CAD lags on the day - European equities lower; S&P 500 futures down 0.8% By Justin Low

NEW YORK, Nov. 29 (Xinhua) -- U.S. stocks realized meaningful growth on Monday following deep losses in the previous session as investors became less nervous about the new COVID-19 variant Omicron. The Dow Jones Industrial Average was up 236.60 points, or 0.68 percent, to 35,135.94. The S&P 500 increased 60.65 points, or 1.32 percent, to 4,655.27. The Nasdaq Composite Index was up 291.18 points, or 1.88 percent,

Stocks push higher The S&P 500 is up 76 points to 4670, breaking the 61.8% retracement level and underscoring the buy-the-dip mentality in stocks. It''s an impressive rebound from Friday''s rout despite the continued uncertainty around omicron. By Adam Button

The S&P 500 has now completed a bearish reversal week. Anlaysts at Credit Suisse continue to look for a deeper setback to 4568/66 objective and pote

Calmer tones prevail after Friday''s rout European indices are up 0.3% to 0.7% while S&P 500 futures are up 0.6% as risk trades are holding up so far on the day. The Omicron variant worries are still the main thing to watch out for but as mentioned earlier, essentially "no news is good news". By Justin Low

Here''s what happened at New Constructs this past week. The post ICYMI: 3Q21 Fundamental Trends in the S&P 500 & Sectors, a Meme-Stock worth $0, a Fitness Stock Running Out of Spin, & Model Portfolio Updates appeared first on New Constructs .

News of a new and more dangerous strain of the coronavirus sent the stock market reeling Friday, where the Dow Jones, S&P 500 and Nasdaq Composite all posted the kind of losses they have not seen in months.

Stocks are opening sharply lower on Wall Street Friday after South Africa found a fast-spreading coronavirus variant and the European Union proposed suspending air travel from southern Africa. The S&P 500 is down 1.4% in early trading, heading for its worst fall since late September and solidly lower for the week. The Dow Jones Industrial Average fell more than 800 points, and the Nasdaq composite is also dropping at the open. Travel and energy stocks are among the biggest losers, with Royal Caribbean, Carnival and Norwegian Cruises all off about 10%. The New York Stock exchange closes early at 1 p.m. Eastern.

The S&P 500 opened lower by 36.83 points, or 0.78%, at 4,664.63, while the Nasdaq Composite dropped 180.85 points, or 1.14%, to 15,664.38 at the opening bell.